Research programme: cancer therapeutics - AllaChemAlternative Names: Androgen receptor antagonists - AllaChem; Inhibitors of androgen receptors - AllaChem; ONC 2-13B
Latest Information Update: 14 Nov 2013
At a glance
- Originator AllaChem
- Class Small molecules; Urea compounds
- Mechanism of Action Androgen receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 14 Nov 2013 Preclinical trials in Cancer in USA (unspecified route)